Heparin-coated cardiopulmonary bypass circuits: current status (Q34375503)

1 August 2017

1 reference

title

Heparin-coated cardiopulmonary bypass circuits: current status (English)

1 reference

1 August 2017

L C Hsu

1

1 reference

1 August 2017

publication date

1 September 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

16

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

417-428

1 reference

Serendipity and the development of heparin and carbon surfaces.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Biocompatibility in heparin-coated extracorporeal circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Impact of closed versus open venous reservoirs on patient outcomes in isolated coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Levels of troponin I and cardiac enzymes after reinfusion of shed blood in coronary operations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Disappearance of glycoprotein Ib from the platelet surface in pericardial blood during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Processing scavenged blood with a cell saver reduces cerebral lipid microembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Biocompatibility in cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Heparin-bonded circuits improve clinical outcomes in emergency coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits (2nd version). The European Working Group on heparin coated extracorporeal circulation circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026765910101600512

10.1177/026765910101600512

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference